![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.005 | 0.11% | 4.65 | 4.41 | 4.89 | 4.53 | 4.51 | 4.53 | 241,784 | 16:35:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.51 | 9.35M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/7/2020 18:39 | A much better read that one Paradise! :-) | ![]() dovey21 | |
24/7/2020 18:36 | And backed up by the goons in London no doubt !! | ![]() paradise city | |
24/7/2020 18:17 | Most of the sceptical scientists work for ivy league Oxford co lol, and don't want little Southampton getting the billions on offer for a solution to this crisis, grates their ego's | ![]() bobaxe1 | |
24/7/2020 18:06 | You enjoy talking to yourself ? There’s a name for loonies like you.. If you are so convinced of your convictions then you should talk it up, then do an almighty life-changing short and watch your prediction come true.... easy money eh? | ![]() adg | |
24/7/2020 18:04 | This is a better read ;-))https://www.theg | ![]() paradise city | |
24/7/2020 17:55 | "Almost two decades ago professors Ratko Djukanovic, Stephen Holgate and Donna Davis discovered that people with asthma and chronic lung disease lacked a protein called interferon beta, which helps fight off the common cold. They worked out that patients’ defences against viral infection could be boosted if the missing protein were replaced. The academics created a company, Synairgen, to turn their discoveries into treatments. It floated on the stock market in 2004, but a deal with AstraZeneca to treat viral infections in asthmatics fell through, and the shares collapsed." ------ notBad in 2decades theyHave managed phase 2 trials fewMre decades toDo phase4 trials ? &they should beSorted. howMany placings needed??? | ![]() andymunchkin | |
24/7/2020 17:40 | I think it's a Scientists job to be sceptical. They tend to doubt by default and then research/test to see if they can prove themselves wrong. | ![]() dovey21 | |
24/7/2020 17:40 | Their egos easily get in the way of unbiased analysis | ![]() dave444 | |
24/7/2020 17:28 | It would be pleasant to see a tick up on Monday ....unsure how big a tick but maybe a certain tabloid may highlight the way 😉😉 | ![]() strongbuy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions